Gata2非编码基因变异作为造血干细胞/原始细胞调动效率的决定因素
Alexandra A Soukup1, Emery H Bresnick1
1Wisconsin Blood Cancer Research Institute, Department of Cell and Regenerative Biology, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Blood advances
|October 23, 2023
概括
在GATA2增强剂中的生殖系变异会损害造血干细胞和原生细胞 (HSPC) 调动. 这一发现对于理解GATA2缺陷综合征和改善干细胞移植疗法至关重要.
科学领域:
- 血液形成的研究研究.
- 血液疾病的遗传学
- 干细胞生物学 干细胞生物学
背景情况:
- 细胞形成的关键调节者GATA2的生殖系遗传变异可能导致GATA2缺乏症综合征,其特征是骨髓衰竭和白血病.
- Gata2 +9.5增强剂对于造血干细胞 (HSC) 的产生和功能至关重要.
- 血造干细胞和原生细胞 (HSPC) 调动对于HSC移植疗法至关重要.
研究的目的:
- 调查特定的Gata2增强剂变体对HSPC动员的影响.
- 确定 Gata2 变种是否会影响通过不同的途径或特定剂介导的调动.
- 评估HSPC移植动员的非编码变异的临床相关性.
主要方法:
- 使用了一种具有特定 Gata2 + 9.5 增强剂变异的小鼠模型.
- 评估HSPC再生,对炎症的反应和动员,使用各种药物,包括G-CSF,IL-8/CXCR2,VLA-4/VCAM1和plerixafor.
- 评估了plerixafor/G-CSF联合治疗在Gata2变种存在时的疗效.
主要成果:
- 该 Gata2 变种显著减弱了 G-CSF 诱导的 HSPC 调动.
- 这种变种还影响了IL-8/CXCR2和VLA-4/VCAM1通路诱导的调动.
- 虽然plerixafor介导的动员没有受到影响,但与G-CSF的联合治疗在变种模型中显示有效性降低.
结论:
- 非编码的GATA2变异通过多个途径对HSPC调动疗效产生重大影响.
- 了解这些影响对于GATA2缺陷综合征患者和优化干细胞移植方案至关重要.
- 这项研究为进一步研究HSPC动员机制提供了有价值的模型.
相关概念视频
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


